What is Global Trial Accelerators™?

Global Trial Accelerators™ is the #1 clinical trials podcast for Medtech, Biopharma, and Radiopharma innovators. Hosted by Jesús E. Moreno, Business Development Director at bioaccess®, and produced by bioaccess® (founded by CEO Julio G. Martinez-Clark), the show helps medical innovators fast-track first-in-human trials by leveraging emerging markets.

How can clinical trials be accelerated in Latin America?

Clinical trials in Latin America can be accelerated through streamlined regulatory pathways, access to treatment-naive patient populations, and partnerships with experienced local CROs like bioaccess®. Countries such as Colombia, Mexico, and Panama offer faster approval timelines compared to the US and EU.

Who hosts the Global Trial Accelerators™ podcast?

The podcast is hosted by Jesús E. Moreno, Business Development Director at bioaccess®, and produced by bioaccess®, the first-in-human CRO founded by CEO Julio G. Martinez-Clark. Together they bring decades of experience in clinical research, regulatory strategy, and medical device innovation across Latin America and global markets.

About

Hosted by Jesús E. Moreno, Business Development Director at bioaccess®, the Global Trial Accelerators™ podcast is the only show built for healthcare startup founders, investors, and innovators navigating first-in-human (FIH) clinical trials. The show is produced by bioaccess® and was founded by Co-Founder & CEO Julio G. Martinez-Clark.

90% of healthcare startups fail — not because their technology doesn’t work, but because they run out of capital before generating the clinical data investors need to see. bioaccess® is the world’s only CRO purpose-built exclusively for FIH trials — serving MedTech, Biopharma, and Radiopharma startups. Each episode delivers actionable strategies from clinical trial pioneers, regulatory strategists, and startup founders who have accelerated their timelines, improved cost-efficiency, and generated regulator-ready clinical data by leveraging Latin America’s 19-country clinical research network.

What You’ll Learn:

• How emerging-market regulatory pathways can shorten ethics-approval timelines compared with the US/EU
• Regulatory pathways across Latin America (Colombia, Mexico, Brazil, Chile, Argentina, Panama, Ecuador, El Salvador, Dominican Republic, Paraguay, and more)
• How to generate FIH clinical data that supports funding rounds, FDA submissions, and strategic acquisitions
• The Innovation Runway: from prototype to clinical milestones before capital runs out
• How emerging markets can improve per-patient and overall trial cost-efficiency
• Market access strategies for registering and commercializing your device across Latin America
• Case studies from dozens of companies — seed-stage startups to Fortune 500 MedTech

Who Should Listen:

• MedTech, Biopharma, and Radiopharma startup founders & CEOs
• Clinical development and regulatory affairs leaders
• Healthcare investors and venture capital partners
• Innovation officers at Fortune 500 medical device companies
• Anyone navigating the path from concept to first-in-human clinical evidence

Subscribe now and join the founders who are accelerating their path to clinical proof — and to exit.

About

About the Hosts